Mar 22, 2016 at 17:51 | Source: CNBC-TV18
The World Health Organization (WHO) has issued a Notice of Concern to Cadila Healthcare over a unit in its Moraiya plant that manufactures vaccines.
Feb 16, 2016 at 08:58 | Source: Reuters
To make a new drug in India, companies need permission from the national drug controller after submitting safety and efficacy data including from local clinical trials. For four years after an approved drug is on the market, firms must submit safety reports, including those on adverse drug reactions.
Feb 15, 2016 at 22:01 | Source: CNBC-TV18
The big demand from Budget 2016 is simple: spend more on healthcare. One suggestion to this end is that the government should take a leaf out of the Singapore government's book and create a universal healthcare insurance scheme.
Feb 03, 2016 at 18:27 | Source: Reuters
The virus is spreading rapidly in the Americas, and WHO officials on Tuesday expressed concern that it could hit Africa and Asia as well. No vaccine has been developed so far.
Jan 13, 2016 at 12:37 | Source: IBNLive.com
"There are 15 dead, including 12 police, one paramilitary, and two civilians," a local police official told AFP, adding that at least 10 people had been wounded, nine of whom were police and one a civilian.
Dec 23, 2015 at 18:44 | Source: PTI
The Philippines' FDA has approved Dengvaxia for the prevention of disease caused by all four dengue types in individuals from 9-45 years of age living in endemic areas, Sanofi said in a statement.
Dec 14, 2015 at 21:58 | Source: CNBC-TV18
Sanofi is committed to delivering the vaccine to India and is in contact with local authorities in the country for providing the drug, says Dr Anh Wartel, Senior Director, Clinical Development, R&D at Sanofi.
Dec 10, 2015 at 20:54 | Source: Reuters
Sanofi Pasteur, the group's vaccines division, said Mexico had approved the preventive treatment, called Dengvaxia, for all four dengue virus serotypes, but only for patients aged 9 to 45 who live in areas where the disease is endemic
Dec 10, 2015 at 08:12 | Source: PTI
Government has also taken over the task of implementing Pentavalent vaccine in its immunization programme at a cost of Rs 750 crore annually from next year which was earlier being taken care of by the Gavi Board.
Dec 02, 2015 at 11:42 | Source: SME Mentor
India is the world leader in generic pharmaceuticals production and ranks among the top 20 pharma exporting countries. India is also a major vaccine producer and these vaccines are exported to over 150 countries.